Would you recommend off-label use of chemoimmunotherapy for metastatic anal squamous cell cancer?

Anal canal squamous cell cancer (SCC) is a relatively uncommon disease, with approximately 10,000 new cases in the United States annually. Chemoradiation treatment is curative for a significant percentage of patients. The rate of locoregional failure was reported to be 10% to 30%, and th...